drugset / Trial / NCT03181035

Correlation of FAZA PET Hypoxia Imaging To 3D Histology in Oral Tongue Cancer

NCT03181035

NaSingle-groupOpen-labelDiagnostic

Summary

This is a pilot study in the form of a prospective Phase II, single centre, single arm hypoxia study of oral tongue cancer with FAZA-PET imaging and pimonidazole targeted IHC of surgical specimens.

Timeline

Start
2018-01-25
Primary completion
2024-09
Completion
2024-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Pimonidazole Diagnostic / imaging agent 0.5 g Oral

Indications